Articles From: Lisa Nelson Named President of Equifax Canada to Supernus Announces Issuance of Fifth U.S. Patent Protecting Trokendi XR(R)


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0980558001&sourceType=1 http://www.ccnmatthews.com/logos/20110929-eq2.jpg TORONTO, ONTARIO --
Sign-up for Lisa Nelson Named President of Equifax Canada investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0980530001&sourceType=1 http://www.ccnmatthews.com/logos/20110203-ithnew21.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for International Tower Hill Mines Announces CAD 8.4 Million Non-Brokered Private Placement investment picks
2014/11/24
Beazer Homes , a top 10 national homebuilder, will be donating a room full of toys worth thousands of dollars to Toys for Tots this Holiday Season.
Sign-up for Beazer Homes Hosts National Toy Drive and Social Media Contest to Donate to Toys for Tots investment picks
2014/11/24
Western Asset Premier Bond Fund, which is listed on the New York Stock Exchange under the symbol “WEA”, today announced the financial position of the Fund as of September 30, 2014.
Sign-up for Western Asset Premier Bond Fund Announces Financial Position as of September 30, 2014 investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a new drug application for omarigliptin, its investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes, to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). “Merck is committed to helping patients with type 2 diabetes and we are excited about the submission of the new drug application for omarigliptin in Japan,” said Peter Stein, M.D., vice president, clinical research, diabetes and endocrinology, Merck Research Laboratories.
Sign-up for Merck Submits New Drug Application to the Japanese Pharmaceuticals and Medical Devices Agency for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes investment picks
2014/11/24
NEW YORK , Nov.
Sign-up for ANN INC. Elects Katie J. Bayne to Board of Directors investment picks
SAN FRANCISCO, Nov.
Sign-up for Diamond Foods Announces First Quarter Fiscal Year 2015 Earnings Conference Call investment picks
Skyworks Solutions, Inc. (NASDAQ:SWKS), an innovator of high performance analog semiconductors enabling a broad range of end markets, today announced that executives will be presenting a company overview at two technology conferences: Each presentation will be Web cast live and archived for replay for one week following the conference on the “Investor Relations” section of Skyworks’ Web site at www.skyworksinc.com .
Sign-up for Skyworks to Present at Upcoming Investor Technology Conferences investment picks
Redbox Remains the Best Value in Home Entertainment with Daily Rental Prices As Low As $1.50 a Day BELLEVUE, Wash.
Sign-up for Outerwall Announces New Daily Rental Prices for Redbox Movies and Video Games investment picks
Merck (MRK) and NewLink Genetics Corp.
Sign-up for Merck, NewLink to collaborate on Ebola vaccine investment picks
2014/11/24
DUBLIN , Nov.
Sign-up for Perrigo Announces The Launch Of A Generic Version Of Astellas' Protopic® Ointment 0.1% And 0.03% investment picks
2014/11/24
ZHONGSHAN, China , Nov.
Sign-up for MY Reports Third Quarter Unaudited Results, Signed Order Backlog Reaches 3.7GW investment picks
PETAH TIKVA, Israel, Nov.
Sign-up for Gilat Reports SkyEdge II-c Orders for SES's Astra Connect Service investment picks
Seagate Technology plc (NASDAQ:STX) today announced that it intends, subject to market and other conditions, to offer up to $300 million aggregate principal amount of senior notes (the “Notes”) in a private placement.
Sign-up for Seagate Technology Announces Offering of $300 Million of Senior Unsecured Notes and Call for Redemption of the Outstanding 6.800% Senior Notes Due 2016 investment picks
SOUTH SAN FRANCISCO, Calif.
Sign-up for Veracyte to Present at the Piper Jaffray 26th Annual Healthcare Conference investment picks
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) and Specialised Therapeutics Australia Pty Ltd (STA), today announced the marketing approval of Iclusig TM (ponatinib) in Australia by the Therapeutic Goods Administration (TGA). The Australian Product Information for Iclusig states that it is indicated for the treatment of adult patients with: Chronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (CML) whose disease is resistant to, or who are intolerant of at least two prior tyrosine kinase inhibitors; or where there is a T315I mutation.
Sign-up for ARIAD and STA Announce Approval of Iclusig (Ponatinib) in Australia investment picks
GUELPH, Ontario , Nov.
Sign-up for Canadian Solar Completes Sale of 28.4 MW Solar Plant in the United States investment picks
- Adds to company's growing renewable portfolio - 20-megawatt solar facility under long-term power purchase agreement RICHMOND, Va.
Sign-up for Dominion Acquires Solar Facility In California investment picks
WHITEHOUSE STATION, N.J. and AMES, Iowa, Nov.
Sign-up for Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine investment picks
Sealed Air Corporation (“Sealed Air” or the “Company”) (NYSE:SEE) today announced that it has extended until 5:00 p.m., New York City time, on November 28, 2014 (such date and time, the “New Expiration Date”), its previously announced solicitation of consents (“Consent Solicitation”) from holders of its 8.375% senior notes due 2021 (the “Notes”) to the proposed amendments to the related indenture.
Sign-up for Sealed Air Announces Extension of Consent Solicitation with Respect to 8.375% Senior Notes Due 2021 investment picks
OMAHA, Neb., Nov.
Sign-up for America First Multifamily Investors, L.P. Announces Recent Investment Activity investment picks
Aerie Pharmaceuticals, Inc. (Nasdaq:AERI) today announced that Richard Rubino, chief financial officer, will present in a fireside chat discussion at the Piper Jaffray 26th Annual Healthcare Conference on Tuesday, December 2, 2014 at 11:30 a.m. Eastern Time in New York, NY.
Sign-up for Aerie Pharmaceuticals to Present at the Piper Jaffray 26th Annual Healthcare Conference investment picks
James M.
Sign-up for Rigel Announces Executive Management Changes investment picks
HARTSVILLE, S.C., Nov.
Sign-up for Sonoco to Host Annual N.Y. Investor Conference on December 5, 2014 investment picks
ROCKVILLE, Md., Nov.
Sign-up for Supernus Announces Issuance of Fifth U.S. Patent Protecting Trokendi XR(R) investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Lisa Nelson Named President of Equifax Canada to Supernus Announces Issuance of Fifth U.S. Patent Protecting Trokendi XR(R)
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent